Abstract
Purpose To assess aqueous and vitreous humour ciprofloxacin concentrations following oral and topical administration of ciprofloxacin in patients with non-inflamed cornea and an intact crystalline lens, and to compare the concentrations of the drug given by either route.
Methods In this prospective study, 34 patients undergoing pars plana vitrectomy for various ocular pathologies were divided into two groups. Eighteen patients received 2 drops of 0.3% ophthalmic solution of ciprofloxacin every 30 min for 3 h and then every 60 min for the next 3 h, and 16 patients received a single oral dose of 1000 mg ciprofloxacin 6 h before surgery. The aqueous and vitreous humour samples were simultaneously harvested after oral or topical administration during pars plana vitrectomy to assess penetration of the drug. These samples were assayed for ciprofloxacin concentrations by a method described previously by us using high-performance liquid chromatography.
Results The aqueous and vitreous humour levels of ciprofloxacin were 0.59 ± 0.06 μg/ml (mean ± SEM) and 0.64 ± 0.06 μg/ml after oral and 0.44 ± 0.07 μg/ml and 0.22 ± 0.04 μg/ml after topical ciprofloxacin administration, respectively. Aqueous humour levels were not statistically significantly different following oral and topical administration (p = 0.069). However, the vitreous level of the drug after oral administration was significantly higher than that after topical administration (p<0.001).
Conclusion Ocular bioavailability of ciprofloxacin in aqueous humour following oral and topical administration is found to be similar when the drug was applied as described above. Penetration of ciprofloxacin into vitreous humour is less than that into aqueous humour after topical administration.
Similar content being viewed by others
Article PDF
References
Neu HC . Microbiologic aspects of fluoroquinolones. Am J Ophthalmol 1991; 112(Suppl): S15–24.
Leibowitz HM . Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol 1991; 112(Suppl): S34–47.
Cokington CD, Hyndiuk RA . Insights from experimental data on ciprofloxacin in the treatment of bacterial keratitis and ocular infections. Am J Ophthalmol 1991; 112(Suppl): S25–8.
Lesk MR, Ammann H, Marcil G, Vinet B, Lamer L, Sebag M . The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans. Am J Ophthalmol 1993; 115: 623–8.
Alfaro DV, Hudson SJ, Rafanan MM, Moss ST, Levy SD . The effect of trauma on the ocular penetration of intravenous ciprofloxacin. Am J Ophthalmol 1996; 122: 678–83.
Hooper DC, Wolfson JS, Ng EY, Swartz MN . Mechanisms of action of and resistance to ciprofloxacin. Am J Med 1987; 82(Suppl 4A): 12–9.
Crump B, Wise R, Dent J . Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrob Agents Chemother 1983; 24: 784–6.
Hoffken G, Lode H, Prinzing C, Borner K, Koeppe P . Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob Agents Chemother 1985; 27: 375–9.
Arcieri G, Griffith E, Gruenwaldt G, Heyd A, O'Brian B, Becker N, August R . Ciprofloxacin: an update on clinical experience. Am J Med 1987; 82(Suppl 4A): 381–6.
Basci NE, Bozkurt A, Kalayci D, Kayaalp SO . Rapid liquid chromatographic assay of ciprofloxacin in human aqueous humor. J Pharm Biomed Anal 1996; 14: 353–6.
Cutarelli PE, Lass JH, Lazarus HM, Putmanet SC, Jacobs MR . Topical fluoroquinolones: antimicrobial activity and in vitro corneal epithelial toxicity. Curr Eye Res 1991; 10: 557–63.
Guzek JP, Chacko D, Kettering JD, Wessels IF, Aprecio RM . Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis. Cornea 1994; 13: 500–4.
Donnenfeld ED, Schrier A, Perry HD, Aulicino T, Gombert ME, Syder R . Penetration of topically applied ciprofloxacin, norfloxacin and ofloxacin into aqueous humor. Ophthalmology 1994; 101: 902–5.
Akkan AG, Mutlu I, Ozyazgan S, Gok A, Yigit U, Ozuner Z, Senses V, Pekel H . Penetration of topically applied ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor of the uninflamed eye. J Chemother 1997; 9: 257–62.
Durmaz B, Marol S, Durmaz R, Oram O, Hepsen IF, Bozkurt A . Aqueous humor penetration of topically applied ciprofloxacin, ofloxacin and tobramycin. Arzneimittelforschung 1997; 47: 413–5.
Çekiç O, Batman C, Totan Y, Yasar Ü, Basci NE, Bozkurt A, Kayaalp SO . Penetration of ofloxacin and ciprofloxacin in aquaeous humor after topical administration. Ophthalmic Surg Lasers 1999; 30: 465–8.
Sweeney G, Fern AI, Lindsay G, Doig MW . Penetration of ciprofloxacin into the aqueous humour of the uninflamed human eye after oral administration. J Antimicrob Chemother 1990; 26: 99–105.
El Baba FZ, Trousdale MD Gauderman WJ, Wagner DG, Liggett PE . Intravitreal penetration of oral ciprofloxacin in humans. Ophthalmology 1992; 99: 483–6.
Keren G, Alhalel A, Bartov E, Cohen RK, Rubinstein E, Segev S, et al. The intravitreal penetration of orally administered ciprofloxacin in humans. Invest Ophthalmol Vis Sci 1991; 32: 2388–92.
Madu AA, Mayers M, Perkins R, Liu W, Drusano GL, Aswani R, et al. Aqueous and vitreous penetration of ciprofloxacin following different modes of systemic administration. Exp Eye Res 1996; 63: 129–36.
Çekiç O, Batman C, Yasar Ü, Basci NE, Bozkurt A, Kayaalp SO . Comparison of aqueous humour and vitreous humour levels of two 0.3% ciprofloxacin eyedrops. Can J Ophthalmol 1998; 33: 373–6.
Author information
Authors and Affiliations
Additional information
This study was supported by a grant from the Scientific and Technical Research Council of Turkey (SBAG-COSTB1-1477) and contributes to the goals of COST Project B1.
The authors have no financial or proprietary interest in the chemicals, instruments and drugs used in this study
Rights and permissions
About this article
Cite this article
Çekiç, O., Batman, C., Yasar, Ü. et al. Human aqueous and vitreous humour levels of ciprofloxacin following oral and topical administration. Eye 13, 555–558 (1999). https://doi.org/10.1038/eye.1999.137
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/eye.1999.137
Keywords
This article is cited by
-
Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model
Eye (2007)
-
Vitreous and aqueous penetration of orally administered moxifloxacin in humans
Eye (2006)
-
Aqueous humour levels of topically applied ciprofloxacin and ofloxacin in the same subjects
Eye (1999)